<bill session="117" type="h" number="7279" updated="2022-12-29T22:18:25Z">
  <state datetime="2022-03-29">REFERRED</state>
  <status>
    <introduced datetime="2022-03-29"/>
  </status>
  <introduced datetime="2022-03-29"/>
  <titles>
    <title type="display">Mental Health Research Accelerator Act of 2022</title>
    <title type="short" as="introduced">Mental Health Research Accelerator Act of 2022</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to provide for a credit against tax for expenses for translational research regarding neurodegenerative diseases and psychiatric conditions.</title>
  </titles>
  <sponsor bioguide_id="T000460"/>
  <cosponsors>
    <cosponsor bioguide_id="K000376" joined="2022-03-29"/>
    <cosponsor bioguide_id="L000582" joined="2022-06-08"/>
    <cosponsor bioguide_id="T000483" joined="2022-08-09"/>
  </cosponsors>
  <actions>
    <action datetime="2022-03-29">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-03-29" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary date="2022-04-01T13:41:33Z" status="Introduced in House">Mental Health Research Accelerator Act of 2022

This bill allows a tax credit through 2031 for 25% of expenses for translational research regarding neurodegenerative diseases and psychiatric conditions. The credit amount is subject to limitations, including an aggregate national limitation of $1 billion in 2022, $2 billion in 2023-2027, and $1 billion in 2028.</summary>
</bill>
